Valuation (76%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 32.12 | 35.73 |
PEG Ratio (TTM) | -0.71 | 9.82 |
P/S Ratio (TTM) | 0.75 | 7.62 |
P/B Ratio (TTM) | 2.32 | 4.45 |
P/FCF Ratio (TTM) | 13.77 | 16.25 |
Price to 5YR AVG Earnings Ratio | 14.04 | 76.78 |
Price to 5YR AVG FCF Ratio | 5.64 | 59.89 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.01% | 6.16% |
ROE (TTM) | 6.99% | 13.75% |
Net Profit Margin (TTM) | 2.33% | 6.24% |
ROIC 5YR AVG | 16.97% | 12.43% |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -33.53% | -2,847.42% | -1,717.98% |
Revenue | -1.23% | 12.32% | 3.01% |
Net Income | -34.55% | -2,784.31% | -1,683.19% |
Cash Flow | -66.02% | 83.96% | 42.60% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.40 | 1.55 |
Quick Ratio (TTM) | 0.82 | 1.10 |
D/E Ratio (TTM) | 1.50 | 0.73 |
Interest Coverage (TTM) | 1.81 | 13.38 |
Piotroski F-Score | 6 | 7 |
Altman Z-Score | 2.11 | 3.87 |
LTL to 5YR AVG FCF | 3.00 | 9.59 |
Shares Outstanding Growth 5YR AVG | -5.34% | 32.99% |